{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:27:41Z","timestamp":1760898461806,"version":"3.37.3"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Novartis Pharma S.A.S."}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0204117","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T13:52:42Z","timestamp":1537278762000},"page":"e0204117","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8284-3743","authenticated-orcid":true,"given":"Olivier","family":"Bouch\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel Le","family":"Cesne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loic","family":"Chaigneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Duffaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Ars\u00e8ne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Remy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Isambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Collard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Priou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Sambuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9golene","family":"Bisot-Locard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bourges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Chabaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1684\/bdc.2010.1041","article-title":"The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists","volume":"97","author":"G Monges","year":"2010","journal-title":"Bull Cancer"},{"issue":"18","key":"ref2","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.ejca.2005.09.009","article-title":"Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study","volume":"41","author":"WG Goettsch","year":"2005","journal-title":"Eur J Cancer"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejca.2006.07.015","article-title":"Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain","volume":"43","author":"J Rubio","year":"2007","journal-title":"Eur J Cancer"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2005.40709.x","article-title":"The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000","volume":"100","author":"T Tran","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.21167","article-title":"Gastrointestinal stromal tumors in Iceland, 1990\u20132003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study","volume":"117","author":"G Tryggvason","year":"2005","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2407-7-230","article-title":"Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study","volume":"7","author":"C Mucciarini","year":"2007","journal-title":"BMC Cancer"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/cncr.20862","article-title":"Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era\u2014a population-based study in western Sweden","volume":"103","author":"B Nilsson","year":"2005","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canep.2015.10.031","article-title":"Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies","volume":"40","author":"K Soreide","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"Suppl 3","key":"ref9","doi-asserted-by":"crossref","first-page":"iii21","DOI":"10.1093\/annonc\/mdu255","article-title":"Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.hoc.2008.11.006","article-title":"Gastrointestinal stromal tumor: a clinical overview","volume":"23","author":"R Quek","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"GD Demetri","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"ref12","first-page":"3034","article-title":"Approval summary: imatinib mesylate in the treatment of metastatic and\/or unresectable malignant gastrointestinal stromal tumors","volume":"8","author":"R Dagher","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1200\/JCO.2007.13.4452","article-title":"Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033","volume":"26","author":"CD Blanke","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2009.24.2099","article-title":"Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients","volume":"28","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref15","unstructured":"Haute Autorit\u00e9 de Sants\u2014GLIVEC. 2014. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.has-sante.fr\/portail\/jcms\/c_1768792\/fr\/glivec\" xlink:type=\"simple\">https:\/\/www.has-sante.fr\/portail\/jcms\/c_1768792\/fr\/glivec<\/ext-link>. Accessed Oct 5 2017."},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1470-2045(10)70222-9","article-title":"Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial","volume":"11","author":"A Le Cesne","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"JE Ware Jr.","year":"1992","journal-title":"Med Care"},{"article-title":"EORTC QLQ-C30 Scoring Manual","year":"2001","author":"P Fayers","key":"ref18"},{"issue":"14","key":"ref19","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM200104053441404","article-title":"Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor","volume":"344","author":"H Joensuu","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/JCO.2007.13.4403","article-title":"Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT","volume":"26","author":"CD Blanke","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9440","key":"ref21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","article-title":"Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial","volume":"364","author":"J Verweij","year":"2004","journal-title":"Lancet"},{"key":"ref22","unstructured":"Glivec (imatinib) summary of product characteristics. Basel, Switzerland, Novartis Pharma AG, <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_Product_Information\/human\/000406\/WC500022207.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_Product_Information\/human\/000406\/WC500022207.pdf<\/ext-link>. Acessed on 17 May 2018."},{"issue":"4","key":"ref23","first-page":"1407","article-title":"Nonadherence to imatinib treatment in patients with gastrointestinal stromal tumors: the ADAGIO study","volume":"31","author":"F Mazzeo","year":"2011","journal-title":"Anticancer Res"},{"key":"ref24","unstructured":"Landi B, Blay JY, Bonvalot S, Bouch\u00e9 O, Coindre JM, Emile JF, et al. Tumeurs stromales gastro-intestinales (GIST). Th\u00e9saurus National de Canc\u00e9rologie Digestive, juillet 2015. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.tncd.org\" xlink:type=\"simple\">http:\/\/www.tncd.org<\/ext-link>. Accessed Oct 5 2017."},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1634\/theoncologist.2012-0474","article-title":"Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumors","volume":"18","author":"P Rutkowski","year":"2013","journal-title":"Oncologist"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0204117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T06:47:49Z","timestamp":1571899669000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0204117"}},"subtitle":[],"editor":[{"given":"Valli","family":"De Re","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0204117","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,9,18]]}}}